Jazz Pharmaceuticals Officer Bruce C. Cozadd Files Form 144 to Sell $1.38M in Stock

Executive Summary

On October 1, 2026, Bruce C. Cozadd, an Officer of Jazz Pharmaceuticals plc ($JAZZ), submitted a Form 144 filing detailing the intended sale of 6,000 ordinary shares with an aggregate market value of approximately $1,381,980. The proposed sale is scheduled around October 1, 2026, through broker Merrill Lynch.

Transaction & Plan Overview

• Shares to be Sold: 6,000 shares (4,393 acquired via stock option on March 1, 2018, and 1,607 acquired via stock option on March 5, 2025).
• Estimated Price per Share: ~$230.33 based on the reported aggregate market value.
• Trading Plan: The planned sale is executed under a pre-established Rule 10b5-1 trading plan adopted on November 26, 2025.
• Prior Transactions: Consistent monthly sales of 6,000 shares each were recorded over the prior three months:
  • September 1, 2026: 6,000 shares ($1,500,780)
  • August 3, 2026: 6,000 shares ($1,517,880)
  • July 1, 2026: 6,000 shares ($1,442,820)

Market Impact & Significance

This transaction represents a routine execution under a long-standing Rule 10b5-1 trading plan. With 64,914,577 shares outstanding, the 6,000 shares to be sold account for less than 0.01% of total shares. Given the programmatic schedule and minimal volume relative to total capitalization, the market significance is assessed as Low.